Bridge City Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Bridge City Capital’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.92M	Sell	92,733 -1,447	-2%	-$45.6K	0.82%	53
2025 Q1	$3.08M	Sell	94,180 -817	-0.9%	-$26.8K	0.93%	47
2024 Q4	$3.44M	Buy	94,997 +761	+0.8%	+$27.5K	0.92%	43
2024 Q3	$2.94M	Buy	94,236 +11,951	+15%	+$373K	0.81%	54
2024 Q2	$2.2M	Buy	82,285 +1,625	+2%	+$43.5K	0.74%	60
2024 Q1	$2.75M	Buy	80,660 +1,985	+3%	+$67.7K	1%	45
2023 Q4	$2.28M	Buy	78,675 +13,378	+20%	+$387K	0.88%	57
2023 Q3	$1.8M	Buy	65,297 +2,469	+4%	+$68.1K	0.91%	56
2023 Q2	$1.89M	Buy	62,828 +38	+0.1%	+$1.14K	0.89%	53
2023 Q1	$2.27M	Sell	62,790 -230	-0.4%	-$8.33K	1.14%	35
2022 Q4	$2.25M	Sell	63,020 -448	-0.7%	-$16K	1.15%	32
2022 Q3	$2.15M	Buy	63,468 +2,116	+3%	+$71.6K	1.18%	30
2022 Q2	$1.77M	Sell	61,352 -109	-0.2%	-$3.15K	0.94%	50
2022 Q1	$1.99M	Sell	61,461 -47,401	-44%	-$1.53M	0.93%	51
2021 Q4	$3.17M	Sell	108,862 -22	-0%	-$641	1.31%	23
2021 Q3	$2.9M	Sell	108,884 -28,898	-21%	-$771K	1.32%	27
2021 Q2	$4.24M	Sell	137,782 -4,581	-3%	-$141K	1.45%	23
2021 Q1	$3.73M	Sell	142,363 -1,450	-1%	-$38K	1.24%	34
2020 Q4	$3.62M	Sell	143,813 -1,496	-1%	-$37.6K	1.37%	27
2020 Q3	$3.03M	Buy	145,309 +21,535	+17%	+$449K	1.45%	22
2020 Q2	$2.94M	Buy	123,774 +1,291	+1%	+$30.7K	1.35%	25
2020 Q1	$2.2M	Buy	122,483 +14,285	+13%	+$257K	1.07%	40
2019 Q4	$2.57M	Buy	108,198 +20,072	+23%	+$476K	1.06%	39
2019 Q3	$2.42M	Buy	88,126 +19,126	+28%	+$526K	1.04%	43
2019 Q2	$2.28M	Buy	69,000 +338	+0.5%	+$11.2K	1.26%	27
2019 Q1	$2.41M	Buy	68,662 +17,256	+34%	+$605K	1.4%	22
2018 Q4	$1.71M	Buy	51,406 +5,563	+12%	+$185K	1.11%	40
2018 Q3	$2.31M	Sell	45,843 -1,952	-4%	-$98.3K	1.43%	20
2018 Q2	$2.86M	Sell	47,795 -1,595	-3%	-$95.5K	1.81%	5
2018 Q1	$2.26M	Buy	49,390 +2,995	+6%	+$137K	1.52%	16
2017 Q4	$1.85M	Hold	46,395	–	–	1.34%	24
2017 Q3	$1.86M	Buy	46,395 +3,740	+9%	+$150K	1.39%	21
2017 Q2	$1.84M	Buy	+42,655	New	+$1.84M	1.53%	18